Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer
Open Access
- 22 May 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Prostate Cancer and Prostatic Diseases
- Vol. 15 (4), 346-352
- https://doi.org/10.1038/pcan.2012.16
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Protective effect of metformin in CD1 mice placed on a high carbohydrate–high fat dietBiochemical and Biophysical Research Communications, 2010
- Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal FunctionDiabetes Care, 2010
- Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategyGynecologic Oncology, 2010
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysisBMC Public Health, 2009
- Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1Journal of Molecular Signaling, 2008
- Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growthEndocrine-Related Cancer, 2008
- Body size and composition and risk of rectal cancer (Australia)Cancer Causes & Control, 2006
- Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990sCirculation, 2006
- Prevalence of Overweight and Obesity in the United States, 1999-2004JAMA, 2006
- AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolismCell Metabolism, 2005